On the other hand, some studies have shown that GnRH-a treatment had no apparent effect on BMI or BMI-SDS and did not exacerbate the prevalence of obesity during longer-term follow-ups [11,15,18,21,43,44]. This evidence concerns the gene GNRH1 and obesity due to melanocortin 4 receptor deficiency.